NURS 6630C- NURS 6630N

 Question 1

1 out of 1 points

Mr. McCullin is 64 years old with Parkinson’s disease. The

PMHNP caring for Mr. McCullin wants to start him on a

dopamine agonist to help manage and treat his condition.

The PHMNP selects this agent because of which action it has

on patients like Mr. McCullin?

Selected

Answer:

D.

D2 receptors are the primary binding site for

dopamine agonists.

 Question 2

1 out of 1 points

Ms. Hill is currently being treated for schizophrenia but has stopped taking

her medications due to some side effects she claims she was

experiencing. She presents to the clinic today with worsening symptoms.

She is experiencing anhedonia, agitation, attentional impairment, and

affective blunting. Which one of the symptoms mentioned is considered a

positive symptom of schizophrenia?

Selected

Answer:

B.

Agitation

 Question 3

1 out of 1 points

The PMHNP evaluates the patient for “fear conditioning”

when he asks:

Selected

Answer:

A.

Have you ever experienced any type

of trauma?

 Question 4

1 out of 1 points

While genes have potential to modify behavior, behavior can

also modify genes. How do genes impact this process?

Selected B.

 1 / 3

Answer: Changes made to proteins lead to changes

in behavior.

 Question 5

1 out of 1 points

The PMHNP is caring for a patient with schizophrenia and is

considering a variety of treatment approaches. The PHMNP

selects a viable treatment that is consistent with the

“dopamine hypothesis of schizophrenia.” What action does

the PMHNP anticipate this treatment having on the patient?

Selected

Answer:

B.

Hyperactivity in the mesolimbic dopamine

pathway mediates the positive symptoms of

schizophrenia.

 Question 6

1 out of 1 points

A patient is diagnosed with schizophrenia. What increases

the patient’s potential to mediate the cognitive symptoms of

the disease?

Selected

Answer:

A.

Achieving underactivity of the mesocorticol

projections to the prefrontal cortex

 Question 7

1 out of 1 points

The PMHNP is assessing a patient in the psychiatric

emergency room. The patient tells the PMHNP that he does

not understand why his depression has not lifted after being

on four different antidepressants over the course of a year.

Which of the following symptoms can be residual symptoms

for patients who do not achieve remission with major

depressive disorder?

Selected

Answer:

D.

A and

C

 Question 8

 2 / 3

1 out of 1 points

Though medications have the ability to target neurotransmitter release

into the synapse by the presynaptic neuron it is not always necessary. The

PMHNP understands that this is because:

Selected

Answer:

C.

Neurotransmitters can spread by

diffusion.

 Question 9

1 out of 1 points

A patient diagnosed with PTSD is prescribed propranolol

(Inderal) and the PMHNP understands that he was prescribed

this medication for what purpose:

Selected

Answer:

B.

Beta blockers are linked to

reconsolidation.

 Question 10

1 out of 1 points

A patient presents with frequent episodes of mania. Which

statement describes an appropriate treatment approach for

this patient?

Selected

Answer:

B.

“The patient could benefit from an

anticonvulsant.”

 Question 11

0 out of 1 points

Mr. Gordon is a middle-aged patient who is taking

antipsychotics. When meeting with the PMHNP, he reports

positive responses to the medication, stating, “I really feel as

though the effects of my depression are going away.” Which

receptor action in antipsychotic medications is believed to be

the most beneficial in producing the effects described by Mr.

Gordon?

Selected

Answer:

B.

D2

Powered by qwivy(www.qwivy.org)

 3 / 3